WESTBROOK, Maine, Aug. 10, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2020 virtual Investor Day on Thursday, August 13, 2020 from 10:00 am ? 12:00 pm ET.
The virtual investor day will include executive presentations followed by a question and answer session. Participating in the event will be members of the IDEXX senior leadership team:
Jay Mazelsky, President and Chief Executive Officer
Brian McKeon, Executive Vice President and Chief Financial Officer
Tina Hunt, Executive Vice President and General Manager for Point-of-Care Diagnostics and Worldwide Operations
Mike Lane, Executive Vice President and General Manager Reference Laboratories and Information Technology
Jim Polewaczyk, Executive Vice President and Chief Commercial Officer
A live webcast and accompanying slide presentations will be available at www.idexx.com/investors. An archived webcast replay of the event will be available approximately one hour following the event at www.idexx.com/investors.
About IDEXX Laboratories IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.
Contact: Investor Relations John Ravis 1-207-556-8155 [email protected]
NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of...
Acadia Pharmaceuticals Inc. today announced that two oral presentations featuring DAYBUEtm (trofinetide) findings in Rett syndrome will be presented at the American Academy of Neurology (AAN) 2024 annual meeting, being held this week in Denver, CO....
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today announced the first patient being dosed in DiaMedica's relaunch of its pivotal...
Jazz Pharmaceuticals plc today announced that it will report its 2024 first quarter financial results on Wednesday, May 1, 2024, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET / 9:30...
In response to the 2024 Federal Budget, Community Food Centres Canada (CFCC) expresses concern over the budget's failure to tackle the pervasive issue of food insecurity in Canada. With 1 in 5 people in Canada living with food insecurity, the federal...
Rallybio Corporation , a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced the presentation of results from a...